Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

Table 1 (abstract P144). Age-dependent assessment of clinical disease activity and incidence of infection

	<12 years		12-17 years		≥18 years
Disease activity by age group	N=33		N=7		N=55
Disease activity by age group	Baseline	36 Months	Baseline	36 Months	Baseline	36 Months
Patient assessment of current disease activity; 0-10, median (min; max).	1.0 (0; 6)	0 (0; 6)	2.0 (0; 5)	0 (0; 4)	2.0 (0; 7)	2.0 (0; 6)
Physician assessment of current disease activity, % of patients absent / mild/moderate	39/52	78/22	43/57	60/40	43/50	57/43
Infection rate by age group N patients (%) [number of events / incidence rate per 100 patient-years]	N=33	N=7	N=55
AE	19 (58) [59 / 69.4]	5 (71) [7 / 37.8]	21 (38) [46 / 35.4]
SAE	4 (12) [5 / 5.9]	2 (29) [4 / 21.6]	3 (6) [3 / 2.2]
SADR	3 (9) [3 / 3.5]	1 (14) [1 / 5.4]	1 (2) [1 / 0.7]

AE, adverse event; SADR, serious adverse drug reaction; SAE, serious adverse event

ISSN: 1546-0096